Tufts Report Finds No Benefit From Routine Pulmonary Artery Catheterization
This article was originally published in The Gray Sheet
Executive SummaryPulmonary artery catheterization for monitoring cardiac function was once common in the intensive care units, but a new technology assessment requested by the government shows there is little evidence that the procedure is effective in critical care settings
You may also be interested in...
Keeping Track: US FDA's Rejection Of First RMAT BLA Blemishes Otherwise Positive Week Of Non-Oncology News
The latest non-oncology drug development news and highlights from our US FDA Performance Tracker.
Stephen Hahn, the Trump administration’s nominee to lead the US FDA, has been approved by the Senate Health, Education, Labor and Pensions (HELP) Committee, with some “no votes” from Democratic senators in leadership positions, and is expected to be considered by the full Senate this week.